Assembly Biosciences Inc. (ASMB) |
|
16.57 0.48 (2.98%)
|
04-18 16:00 |
|
Open: |
16.07 |
Pre. Close: |
16.09 |
|
High:
|
16.63 |
Low:
|
15.715 |
|
Volume:
|
500,202 |
Market Cap:
|
423M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
16.644 - 16.762 |
16.762 - 16.853 |
|
Low:
|
15.508 - 15.628 |
15.628 - 15.722 |
|
Close:
|
16.407 - 16.6 |
16.6 - 16.75 |
|
|
|
Technical analysis |
as of: 2019-04-18 4:34:21 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 21.17 One year: 24.77 |
| Support: |
Support1: 13.13 Support2: 10.92 |
| Resistance: |
Resistance1: 18.12 Resistance2: 21.21 |
| Pivot: |
18.73  |
| Moving Average: |
MA(5): 16.50 MA(20): 18.70
MA(100): 21.29 MA(250): 30.58 |
| MACD: |
MACD(12,26): -0.91 Signal(9): -0.56 |
| Stochastic oscillator: |
%K(14,3): 39.32 %D(3): 35.38 |
| RSI: |
RSI(14): 39.58 |
| 52-week: |
High: 48.91 Low: 13.13 Change(%): -64.6 |
| Average Vol(K): |
3-Month: 31298 10-Days: 71184 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ASMB has closed above bottom band by 20.1%. Bollinger Bands are 57.6% wider than normal. The large width of the bands suggest high volatility as compared to ASMB's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Mon, 15 Apr 2019 19:10:13 Z
Here's Why Assembly Biosciences Is Slipping Today
Mon, 15 Apr 2019 19:06:54 Z
Monday Sector Laggards: Biotechnology, Drugs
Mon, 15 Apr 2019 13:46:41 Z
Health Care Sector Update for 04/15/2019: ASMB, APHA, CLVS, JNJ, PFE, MRK, ABT, AMGN
Wed, 20 Feb 2019 06:06:52 Z
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects
Thu, 31 Jan 2019 16:57:37 Z
Mylan (MYL) Jumps: Stock Rises 7.1%
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
25.55 |
| Shares Float (M) |
23.64 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
117.70 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-4.000 |
|
EPS Est. Current Year
|
|
|
EPS Est. Next Year
|
|
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
-2.351 |
|
Book Value (p.s.)
|
2.490 |
|
PEG Ratio
|
-0.26 |
|
Profit Margin
|
|
|
Operating Margin
|
-597.37 |
|
Return on Assets (ttm)
|
-42.2 |
|
Return on Equity (ttm)
|
-56.9 |
|
Qtrly Rev. Growth
|
12.7 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-64.96 |
|
Levered Free Cash Flow (M)
|
-22.75 |
Stock Valuations |
|
P/E
|
-4.14 |
|
P/E Growth Ratio
|
0.03 |
|
P/BV
|
6.65 |
|
P/S
|
651328448.00 |
|
P/CF
|
-6.52 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2014-07-14 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
